Not A Member?       Forget Password?
          Click HERE                   Click HERE
   and Register FREE
   LATEST INTERVIEWS
-
Fibrocell Science, Inc.
( :FCSC ) / David Pernock
 
-
diaDexus, Inc.
( OTCBB:DDXS ) / Dr. Brian Ward
 
-
NovaBay Pharmaceuticals, Inc.
( NYSE:NBY ) / Ron Najafi, Ph.D. Thomas Paulson, M.B.A.
 
-
EnerJex Resources, Inc.
( OTCBB:ENRJ ) / Robert Watson, Jr. Atticus Lowe
 
-
League Now Holdings Corporation (Infiniti Systems Group, Inc.)
( OTCBB:LNWZ ) / Mr. John L. Bianco Mr. D. Bruce Veness
 
-
Sunshine Biopharma, inc.
( OTCBB:SBFM ) / Steve N. Slilaty Camille Sebaaly
 
-
TheraBiogen, Inc.
( OTCBB:TRAB ) / Kelly Hickel
 
-
Trimedyne, Inc.
( OTCBB:TMED ) / Marvin P. Loeb
 
-
XsunX Inc.
( OTCBB:XSNX ) / Mr. Tom M. Djokovich
 
 
   CEOcast WEEKLY NEWSLETTER  
  
December 15, 2014 CEOcast Weekly Newsletter
Companies featured in the current edition of the newsletter: ENZ Stocks tumbled dramatically as the energy sector continued to decline, bringing a spectacular ending to the week despite a range of goo... Click here for more...
 
   
   STOCKS ON THE MOVE  

Enzo Biochem, Inc.
 

Enzo Biochem is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. Founded in 1976, the company has concentrated on the development of enabling technologies in the areas of gene regulation and gene modification. Many of Enzo’s technologies are applicable to the biomedical and pharmaceutical research markets, and they are further using these technologies as a platform for entry into the clinical diagnostics market. Today, Enzo technologies and products are recognized as the key tools in non-radioactive gene labeling used by researchers worldwide. Additionally, Enzo's work in gene analysis has led to development of a number of significant therapeutic candidates for the treatment of viral and immunological based disorders, several of which are in various phases of human clinical trials. In the course of their extensive research and development activities, Enzo has built a significant patent position consisting of numerous pioneer patents and applications that encompass the company’s core technologies.

 
Kindred Biosciences, Inc.
 
Kindred Biosciences is a development stage biopharmaceutical company focused on saving and improving the lives of pets.  Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy.  The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses.  The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
 

 
     
 
 
Copyright © 2001-2014. All Rights Reserved. Disclaimer | Privacy Policy